Induced pluripotent stem cells: Emerging techniques for nuclear reprogramming

Antioxidants and Redox Signaling

Volumn 15, Issue 7, 2011, Pages 1799-1820

  Han, Ji Woong ^a   Yoon, Young Sup ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2;

CELL LINE; CELL NUCLEUS TRANSPLANTATION; EMBRYONIC STEM CELL; INNER CELL MASS; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; SOMATIC CELL; TRANSGENICS;

ADENOVIRIDAE; ANIMALS; CELL CULTURE TECHNIQUES; CELL DEDIFFERENTIATION; CHROMATIN; ENZYME INHIBITORS; EPIGENESIS, GENETIC; GENE EXPRESSION; GENE REGULATORY NETWORKS; GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LENTIVIRUS; MICRORNAS; RECOMBINANT PROTEINS; REGENERATIVE MEDICINE; TRANSCRIPTION FACTORS;

IPS;

EID: 80051734732     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2010.3814     Document Type: Review

References (221)

1. Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F, Vassena R, Bilic J, Pekarik V, Tiscornia G, Edel M, Boue S, Izpisua Belmonte JC. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26: 1276-1284, 2008.
2. Akagi K, Suzuki T, Stephens RM, Jenkins NA, and Copeland NG. RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res 32: D523-D527, 2004. (Pubitemid 38081713)
3. Alon U. Network motifs: theory and experimental approaches. Nat Rev Genet 8: 450-461, 2007. (Pubitemid 46789247)
4. Amabile G and Meissner A. Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends Mol Med 15: 59-68, 2009.
5. Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, Takahashi K, Chiba T, and Yamanaka S. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321: 699-702, 2008.
6. Armstrong L, Hughes O, Yung S, Hyslop L, Stewart R, Wappler I, Peters H, Walter T, Stojkovic P, Evans J, Stojkovic M, and Lako M. The role of PI3K/AKT, MAPK/ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum Mol Genet 15: 1894-1913, 2006. (Pubitemid 43821780)
7. Azuara V, Perry P, Sauer S, Spivakov M, Jorgensen HF, John RM, Gouti M, Casanova M, Warnes G, Merkenschlager M, and Fisher AG. Chromatin signatures of pluripotent cell lines. Nat Cell Biol 8: 532-538, 2006.
8. Bendall SC, Stewart MH, Menendez P, George D, Vijayaragavan K, Werbowetski-Ogilvie T, Ramos-Mejia V, Rouleau A, Yang J, Bosse M, Lajoie G, and Bhatia M. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 448: 1015-1021, 2007. (Pubitemid 47345578)
9. Bernstein BE, Meissner A, and Lander ES. The mammalian epigenome. Cell 128: 669-681, 2007. (Pubitemid 46273573)
10. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, Meissner A, Wernig M, Plath K, Jaenisch R, Wagschal A, Feil R, Schreiber SL, and Lander ES. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125: 315-126, 2006.
11. Boland MJ, Hazen JL, Nazor KL, Rodriguez AR, Gifford W, Martin G, Kupriyanov S, and Baldwin KK. Adult mice generated from induced pluripotent stem cells. Nature 461: 91-94, 2009.
12. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, Gifford DK, Melton DA, Jaenisch R, and Young RA. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122: 947-956, 2005. (Pubitemid 41345211)
13. Boyer LA, Plath K, Zeitlinger J, Brambrink T, Medeiros LA, Lee TI, Levine SS, Wernig M, Tajonar A, Ray MK, Bell GW, Otte AP, Vidal M, Gifford DK, Young RA, and Jaenisch R. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441: 349-353, 2006. (Pubitemid 44050199)
14. Brambrink T, Foreman R, Welstead GG, Lengner CJ, Wernig M, Suh H, and Jaenisch R. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2: 151-159, 2008. (Pubitemid 351168714)
15. Briggs R and King TJ. Transplantation of living nuclei from blastula cells into enucleated frogs' eggs. Proc Natl Acad Sci USA 38: 455-463, 1952.
16. Brons IG, Smithers LE, Trotter MW, Rugg-Gunn P, Sun B, Chuva de Sousa Lopes SM, Howlett SK, Clarkson A, Ahrlund-Richter L, Pedersen RA, and Vallier L. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448: 191-195, 2007. (Pubitemid 47067373)
17. Buecker C, Chen HH, Polo JM, Daheron L, Bu L, Barakat TS, Okwieka P, Porter A, Gribnau J, Hochedlinger K, and Geijsen N. A murine ESC-like state facilitates transgenesis and homologous recombination in human pluripotent stem cells. Cell Stem Cell 6: 535-546, 2010.
18. Campbell KH, McWhir J, Ritchie WA, and Wilmut I. Sheep cloned by nuclear transfer from a cultured cell line. Nature 380: 64-66, 1996. (Pubitemid 26076237)
19. Carey BW, Markoulaki S, Hanna J, Saha K, Gao Q, Mitalipova M, and Jaenisch R. Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc Natl Acad Sci USA 106: 157-162, 2009.
20. Cartwright P, McLean C, Sheppard A, Rivett D, Jones K, and Dalton S. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 132: 885-896, 2005. (Pubitemid 40484924)
21. Carvajal-Vergara X, Sevilla A, D'Souza SL, Ang YS, Schaniel C, Lee DF, Yang L, Kaplan AD, Adler ED, Rozov R, Ge Y, Cohen N, Edelmann LJ, Chang B, Waghray A, Su J, Pardo S, Lichtenbelt KD, Tartaglia M, Gelb BD, and Lemischka IR. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 465: 808-812, 2010.
22. Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, and Smith A. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113: 643-655, 2003. (Pubitemid 36694189)
23. Chang CW, Lai YS, Pawlik KM, Liu K, Sun CW, Li C, Schoeb TR, and Townes TM. Polycistronic lentiviral vector for "hit and run" reprogramming of adult skin fibroblasts to induced pluripotent stem cells. Stem Cells 27: 1042-1049, 2009.
24. Chang Y, Zhang X, Horton JR, Upadhyay AK, Spannhoff A, Liu J, Snyder JP, Bedford MT, and Cheng X. Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294. Nat Struct Mol Biol 16: 312-317, 2009.
25. Chen G, Hou Z, Gulbranson DR, and Thomson JA. Actinmyosin contractility is responsible for the reduced viability of dissociated human embryonic stem cells. Cell Stem Cell 7: 240-248, 2010.
26. Cho HJ, Lee CS, Kwon YW, Paek JS, Lee SH, Hur J, Lee EJ, Roh TY, Chu IS, Leem SH, Kim Y, Kang HJ, Park YB, and Kim HS. Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation. Blood 116: 386-395, 2010.
27. Darr H, Mayshar Y, and Benvenisty N. Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features. Development 133: 1193-1201, 2006.
28. Davis RL, Weintraub H, and Lassar AB. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Ce0ll 51: 987-1000, 1987.
29. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, Croft GF, Saphier G, Leibel R, Goland R, Wichterle H, Henderson CE, and Eggan K. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321: 1218-1221, 2008.
30. Dong KB, Maksakova IA, Mohn F, Leung D, Appanah R, Lee S, Yang HW, Lam LL, Mager DL, Schubeler D, Tachibana M, Shinkai Y, and Lorincz MC. DNA methylation in ES cells requires the lysine methyltransferase G9a but not its catalytic activity. EMBO J 27: 2691-2701, 2008.
31. Drayton S and Peters G. Immortalisation and transformation revisited. Curr Opin Genet Dev 12: 98-104, 2002. (Pubitemid 34094997)
32. Ducray C, Pommier JP, Martins L, Boussin FD, and Sabatier L. Telomere dynamics, end-to-end fusions and telomerase activation during the human fibroblast immortalization process. Oncogene 18: 4211-4223, 1999. (Pubitemid 29377852)
33. Ebert AD, Yu J, Rose FF Jr, Mattis VB, Lorson CL, Thomson JA, and Svendsen CN. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457: 277-280, 2009.
34. Eggan K, Akutsu H, Loring J, Jackson-Grusby L, Klemm M, Rideout WM 3rd, Yanagimachi R, and Jaenisch R. Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation. Proc Natl Acad Sci USA 98: 6209-6214, 2001. (Pubitemid 32488218)
35. Egli D, Birkhoff G, and Eggan K. Mediators of reprogramming: transcription factors and transitions through mitosis. Nat Rev Mol Cell Biol 9: 505-516, 2008. (Pubitemid 351890351)
36. Epsztejn-Litman S, Feldman N, Abu-Remaileh M, Shufaro Y, Gerson A, Ueda J, Deplus R, Fuks F, Shinkai Y, Cedar H, and Bergman Y. De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. Nat Struct Mol Biol 15: 1176-1183, 2008.
37. Esteban MA, Xu J, Yang J, Peng M, Qin D, Li W, Jiang Z, Chen J, Deng K, Zhong M, Cai J, Lai L, and Pei D. Generation of induced pluripotent stem cell lines from Tibetan miniature pig. J Biol Chem 284: 17634-17640, 2009.
38. Evans MJ and Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 292: 154-156, 1981. (Pubitemid 11050741)
39. Feldman N, Gerson A, Fang J, Li E, Zhang Y, Shinkai Y, Cedar H, and Bergman Y. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat Cell Biol 8: 188-194, 2006.
40. Fusaki N, Ban H, Nishiyama A, Saeki K, and Hasegawa M. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 85: 348-362, 2009.
41. Ghosh Z, Wilson KD, Wu Y, Hu S, Quertermous T, and Wu JC. Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS One 5: e8975, 2010.
42. Giorgetti A, Montserrat N, Aasen T, Gonzalez F, Rodriguez-Piza I, Vassena R, Raya A, Boue S, Barrero MJ, Corbella BA, Torrabadella M, Veiga A, and Izpisua Belmonte JC. Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 5: 353-357, 2009.
43. Gonzalez F, Barragan Monasterio M, Tiscornia G, Montserrat Pulido N, Vassena R, Batlle Morera L, Rodriguez Piza I, and Izpisua Belmonte JC. Generation of mouseinduced pluripotent stem cells by transient expression of a single nonviral polycistronic vector. Proc Natl Acad Sci USA 106: 8918-8922, 2009.
44. Guenther MG, Levine SS, Boyer LA, Jaenisch R, and Young RA. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130: 77-88, 2007. (Pubitemid 47031323)
45. Gurdon JB. The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. J Embryol Exp Morphol 10: 622-640, 1962.
46. Gurdon JB and Uehlinger V. "Fertile" intestine nuclei. Nature 210: 1240-1241, 1966.
47. Haase A, Olmer R, Schwanke K, Wunderlich S, Merkert S, Hess C, Zweigerdt R, Gruh I, Meyer J, Wagner S, Maier LS, Han DW, Glage S, Miller K, Fischer P, Scholer HR, and Martin U. Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell 5: 434-441, 2009.
48. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, Lim A, Osborne CS, Pawliuk R, Morillon E, Sorensen R, Forster A, Fraser P, Cohen JI, de Saint Basile G, Alexander I, Wintergerst U, Frebourg T, Aurias A, Stoppa-Lyonnet D, Romana S, Radford-Weiss I, Gross F, Valensi F, Delabesse E, Macintyre E, Sigaux F, Soulier J, Leiva LE, Wissler M, et al. MO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302: 415-419, 2003. (Pubitemid 37296260)
49. Hanna J, Cheng AW, Saha K, Kim J, Lengner CJ, Soldner F, Cassady JP, Muffat J, Carey BW, and Jaenisch R. Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci USA 107: 9222-9227, 2010.
50. Hanna J, Markoulaki S, Schorderet P, Carey BW, Beard C, Wernig M, Creyghton MP, Steine EJ, Cassady JP, Foreman R, Lengner CJ, Dausman JA, and Jaenisch R. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 133: 250-264, 2008. (Pubitemid 351508307)
51. Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, Cassady JP, Beard C, Brambrink T, Wu LC, Townes TM, and Jaenisch R. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318: 1920-1923, 2007.
52. Hawley RG. Does retroviral insertional mutagenesis play a role in the generation of induced pluripotent stem cells? Mol Ther 16: 1354-1355, 2008.
53. Herbig U and Sedivy JM. Regulation of growth arrest in senescence: telomere damage is not the end of the story. Mech Ageing Dev 127: 16-24, 2006. (Pubitemid 41713510)
54. Hester ME, Song S, Miranda CJ, Eagle A, Schwartz PH, and Kaspar BK. Two factor reprogramming of human neural stem cells into pluripotency. PLoS One 4: e7044, 2009.
55. Honda A, Hirose M, Hatori M, Matoba S, Miyoshi H, Inoue K, and Ogura A. Generation of induced pluripotent stem cells in rabbits: potential experimental models for human regenerative medicine. J Biol Chem 285: 31362-31369, 2010.
56. Hong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O, Nakagawa M, Okita K, and Yamanaka S. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460: 1132-1135, 2009.
57. Houbaviy HB, Murray MF, and Sharp PA. Embryonic stem cell-specific MicroRNAs. Dev Cell 5: 351-358, 2003. (Pubitemid 37006477)
58. Howe SJ, Mansour MR, Schwarzwaelder K, Bartholomae C, Hubank M, Kempski H, Brugman MH, Pike-Overzet K, Chatters SJ, de Ridder D, Gilmour KC, Adams S, Thornhill SI, Parsley KL, Staal FJ, Gale RE, Linch DC, Bayford J, Brown L, Quaye M, Kinnon C, Ancliff P, Webb DK, Schmidt M, von Kalle C, Gaspar HB, and Thrasher AJ. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest 118: 3143-3150, 2008.
59. Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, Chen AE, and Melton DA. Induction of pluripotent stem cells by defined factors is greatly improved by smallmolecule compounds. Nat Biotechnol 26: 795-797, 2008. (Pubitemid 351961456)
60. Humphrey RK, Beattie GM, Lopez AD, Bucay N, King CC, Firpo MT, Rose-John S, and Hayek A. Maintenance of pluripotency in human embryonic stem cells is STAT3 independent. Stem Cells 22: 522-530, 2004. (Pubitemid 39014568)
61. Ichida JK, Blanchard J, Lam K, Son EY, Chung JE, Egli D, Loh KM, Carter AC, Di Giorgio FP, Koszka K, Huangfu D, Akutsu H, Liu DR, Rubin LL, and Eggan K. A smallmolecule inhibitor of Tgf-beta signaling replaces Sox2 in reprogramming by inducing nanog. Cell Stem Cell 5: 491-503, 2009.
62. Ivanova N, Dobrin R, Lu R, Kotenko I, Levorse J, DeCoste C, Schafer X, Lun Y, and Lemischka IR. Dissecting selfrenewal in stem cells with RNA interference. Nature 442: 533-538, 2006. (Pubitemid 44167907)
63. Jaenisch R and Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132: 567-582, 2008. (Pubitemid 351253686)
64. Jenuwein T and Allis CD. Translating the histone code. Science 293: 1074-1080, 2001. (Pubitemid 32758077)
65. Judson RL, Babiarz JE, Venere M, and Blelloch R. Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat Biotechnol 27: 459-461, 2009.
66. Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, and Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458: 771-775, 2009.
67. Kang L, Wang J, Zhang Y, Kou Z, and Gao S. iPS cells can support full-term development of tetraploid blastocystcomplemented embryos. Cell Stem Cell 5: 135-138, 2009.
68. Kawamura T, Suzuki J, Wang YV, Menendez S, Morera LB, Raya A, Wahl GM, and Belmonte JC. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460: 1140-1144, 2009.
69. Kim D, Kim CH, Moon JI, Chung YG, Chang MY, Han BS, Ko S, Yang E, Cha KY, Lanza R, and Kim KS. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4: 472-476, 2009.
70. Kim J, Chu J, Shen X, Wang J, and Orkin SH. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132: 1049-1061, 2008. (Pubitemid 351381745)
71. Kim JB, Sebastiano V, Wu G, Arauzo-Bravo MJ, Sasse P, Gentile L, Ko K, Ruau D, Ehrich M, van den Boom D, Meyer J, Hubner K, Bernemann C, Ortmeier C, Zenke M, Fleischmann BK, Zaehres H, and Scholer HR. Oct4-induced pluripotency in adult neural stem cells. Cell 136: 411-419, 2009.
72. Kim JB, Zaehres H, Wu G, Gentile L, Ko K, Sebastiano V, Arauzo-Bravo MJ, Ruau D, Han DW, Zenke M, and Scholer HR. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 454: 646-650, 2008.
73. Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, Kim J, Aryee MJ, Ji H, Ehrlich LI, Yabuuchi A, Takeuchi A, Cunniff KC, Hongguang H, McKinney-Freeman S, Naveiras O, Yoon TJ, Irizarry RA, Jung N, Seita J, Hanna J, Murakami P, Jaenisch R, Weissleder R, Orkin SH, Weissman IL, Feinberg AP, and Daley GQ. Epigenetic memory in induced pluripotent stem cells. Nature 467, 285-290, 2010.
74. Kinoshita K, Ura H, Akagi T, Usuda M, Koide H, and Yokota T. GABPalpha regulates Oct-3/4 expression in mouse embryonic stem cells. Biochem Biophys Res Commun 353: 686-691, 2007. (Pubitemid 46048724)
75. Kloosterman WP and Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell 11: 441-450, 2006. (Pubitemid 44430905)
76. Ko SY, Kang HY, Lee HS, Han SY, and Hong SH. Identification of Jmjd1a as a STAT3 downstream gene in mES cells. Cell Struct Funct 31: 53-62, 2006.
77. Krawetz RJ, Li X, and Rancourt DE. Human embryonic stem cells: caught between a ROCK inhibitor and a hard place. Bioessays 31: 336-343, 2009.
78. Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA, and Jacks T. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci USA 105: 3903-3908, 2008. (Pubitemid 351723497)
79. Kunisato A, Wakatsuki M, Kodama Y, Shinba H, Ishida I, and Nagao K. Generation of induced pluripotent stem (iPS) cells by efficient reprogramming of adult bone marrow cells. Stem Cells Dev 19: 229-238, 2009.
80. Kuroda T, Tada M, Kubota H, Kimura H, Hatano SY, Suemori H, Nakatsuji N, and Tada T. Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol Cell Biol 25: 2475-2485, 2005. (Pubitemid 40354640)
81. Lan F, Bayliss PE, Rinn JL, Whetstine JR, Wang JK, Chen S, Iwase S, Alpatov R, Issaeva I, Canaani E, Roberts TM, Chang HY, and Shi Y. A histone H3 lysine 27 demethylase regulates animal posterior development. Nature 449: 689-694, 2007. (Pubitemid 47552096)
82. Lee G, Papapetrou EP, Kim H, Chambers SM, Tomishima MJ, Fasano CA, Ganat YM, Menon J, Shimizu F, Viale A, Tabar V, Sadelain M, and Studer L. Modelling pathogenesis and treatment of familial dysautonomia using patientspecific iPSCs. Nature 461: 402-406, 2009.
83. Lee JH, Hart SR, and Skalnik DG. Histone deacetylase activity is required for embryonic stem cell differentiation. Genesis 38: 32-38, 2004. (Pubitemid 38197607)
84. Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, Kumar RM, Chevalier B, Johnstone SE, Cole MF, Isono K, Koseki H, Fuchikami T, Abe K, Murray HL, Zucker JP, Yuan B, Bell GW, Herbolsheimer E, Hannett NM, Sun K, Odom DT, Otte AP, Volkert TL, Bartel DP, Melton DA, Gifford DK, Jaenisch R, and Young RA. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125: 301-313, 2006. (Pubitemid 44313811)
85. Lerou PH and Daley GQ. Therapeutic potential of embryonic stem cells. Blood Rev 19: 321-331, 2005. (Pubitemid 41571932)
86. Li C, Zhou J, Shi G, Ma Y, Yang Y, Gu J, Yu H, Jin S, Wei Z, Chen F, and Jin Y. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells. Hum Mol Genet 18: 4340-4349, 2009.
87. Li H, Collado M, Villasante A, Strati K, Ortega S, Canamero M, Blasco MA, and Serrano M. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 460: 1136-1139, 2009.
88. Li J, Wang G, Wang C, Zhao Y, Zhang H, Tan Z, Song Z, Ding M, and Deng H. MEK/ERK signaling contributes to the maintenance of human embryonic stem cell selfrenewal. Differentiation 75: 299-307, 2007. (Pubitemid 46434953)
89. Li W, Wei W, Zhu S, Zhu J, Shi Y, Lin T, Hao E, Hayek A, Deng H, and Ding S. Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell 4: 16-19, 2009.
90. Li W, Zhou H, Abujarour R, Zhu S, Joo JY, Lin T, Hao E, Scholer HR, Hayek A, and Ding S. Generation of human induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells 4: 381-384, 2009.
91. Li Z, Dullmann J, Schiedlmeier B, Schmidt M, von Kalle C, Meyer J, Forster M, Stocking C, Wahlers A, Frank O, Ostertag W, Kuhlcke K, Eckert HG, Fehse B, and Baum C. Murine leukemia induced by retroviral gene marking. Science 296: 497, 2002. (Pubitemid 34408663)
92. Liao J, Cui C, Chen S, Ren J, Chen J, Gao Y, Li H, Jia N, Cheng L, Xiao H, and Xiao L. Generation of induced pluripotent stem cell lines from adult rat cells. Cell Stem Cell 4: 11-15, 2009.
93. Liu H, Ye Z, Kim Y, Sharkis S, and Jang YY. Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes. Hepatology 51: 1810-1819, 2010.
94. Liu H, Zhu F, Yong J, Zhang P, Hou P, Li H, Jiang W, Cai J, Liu M, Cui K, Qu X, Xiang T, Lu D, Chi X, Gao G, Ji W, Ding M, and Deng H. Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts. Cell Stem Cell 3: 587-590, 2008.
95. Loh YH, Agarwal S, Park IH, Urbach A, Huo H, Heffner GC, Kim K, Miller JD, Ng K, and Daley GQ. Generation of induced pluripotent stem cells from human blood. Blood 113: 5476-5479, 2009.
96. Loh YH, Hartung O, Li H, Guo C, Sahalie JM, Manos PD, Urbach A, Heffner GC, Grskovic M, Vigneault F, Lensch MW, Park IH, Agarwal S, Church GM, Collins JJ, Irion S, and Daley GQ. Reprogramming of T cells from human peripheral blood. Cell Stem Cell 7: 15-19, 2010.
97. Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, Chen X, Bourque G, George J, Leong B, Liu J, Wong KY, Sung KW, Lee CW, Zhao XD, Chiu KP, Lipovich L, Kuznetsov VA, Robson P, Stanton LW, Wei CL, Ruan Y, Lim B, and Ng HH. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 38: 431-440, 2006.
98. Lowry WE, Richter L, Yachechko R, Pyle AD, Tchieu J, Sridharan R, Clark AT, and Plath K. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci USA 105: 2883-2888, 2008. (Pubitemid 351723638)
99. Lyssiotis CA, Foreman RK, Staerk J, Garcia M, Mathur D, Markoulaki S, Hanna J, Lairson LL, Charette BD, Bouchez LC, Bollong M, Kunick C, Brinker A, Cho CY, Schultz PG, and Jaenisch R. Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc Natl Acad Sci USA 106: 8912-8917, 2009.
100. Maehr R, Chen S, Snitow M, Ludwig T, Yagasaki L, Goland R, Leibel RL, and Melton DA. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci USA 106: 15768-15773, 2009.
101. Maherali N, Ahfeldt T, Rigamonti A, Utikal J, Cowan C, and Hochedlinger K. A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 3: 340-345, 2008.
102. Maherali N and Hochedlinger K. TGFbeta signal inhibition cooperates in the induction of iPSCs and replaces Sox2 and cMyc. Curr Biol 19: 1718-1723, 2009.
103. Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, Arnold K, Stadtfeld M, Yachechko R, Tchieu J, Jaenisch R, Plath K, and Hochedlinger K. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1: 55-70, 2007.
104. Mali P, Ye Z, Hommond HH, Yu X, Lin J, Chen G, Zou J, and Cheng L. Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts. Stem Cells 26: 1998-2005, 2008.
105. Marion RM, Strati K, Li H, Murga M, Blanco R, Ortega S, Fernandez-Capetillo O, Serrano M, and Blasco MA. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460: 1149-1153, 2009.
106. Markoulaki S, Hanna J, Beard C, Carey BW, Cheng AW, Lengner CJ, Dausman JA, Fu D, Gao Q, Wu S, Cassady JP, and Jaenisch R. Transgenic mice with defined combinations of drug-inducible reprogramming factors. Nat Biotechnol 27: 169-171, 2009.
107. Marson A, Foreman R, Chevalier B, Bilodeau S, Kahn M, Young RA, and Jaenisch R. Wnt signaling promotes reprogramming of somatic cells to pluripotency. Cell Stem Cell 3: 132-135, 2008.
108. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 78: 7634-7638, 1981. (Pubitemid 12186197)
109. Masui S, Nakatake Y, Toyooka Y, Shimosato D, Yagi R, Takahashi K, Okochi H, Okuda A, Matoba R, Sharov AA, Ko MS, and Niwa H. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol 9: 625-635, 2007. (Pubitemid 47214724)
110. Mazzini L, Ferrero I, Luparello V, Rustichelli D, Gunetti M, Mareschi K, Testa L, Stecco A, Tarletti R, Miglioretti M, Fava E, Nasuelli N, Cisari C, Massara M, Vercelli R, Oggioni GD, Carriero A, Cantello R, Monaco F, and Fagioli F. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a phase I clinical trial. Exp Neurol 223: 229-237, 2009.
111. Mazzini L, Mareschi K, Ferrero I, Vassallo E, Oliveri G, Nasuelli N, Oggioni GD, Testa L, and Fagioli F. Stem cell treatment in amyotrophic lateral sclerosis. J Neurol Sci 265: 78-83, 2008.
112. Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, Sivachenko A, Zhang X, Bernstein BE, Nusbaum C, Jaffe DB, Gnirke A, Jaenisch R, and Lander ES. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454: 766-770, 2008.
113. Meissner A, Wernig M, and Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol 25: 1177-1181, 2007. (Pubitemid 47538112)
114. Melton C, Judson RL, and Blelloch R. Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature 463: 621-626, 2010.
115. Meshorer E, Yellajoshula D, George E, Scambler PJ, Brown DT, and Misteli T. Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev Cell 10: 105-116, 2006. (Pubitemid 43025681)
116. Mikkelsen TS, Hanna J, Zhang X, Ku M, Wernig M, Schorderet P, Bernstein BE, Jaenisch R, Lander ES, and Meissner A. Dissecting direct reprogramming through integrative genomic analysis. Nature 454: 49-55, 2008. (Pubitemid 351931978)
117. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alvarez P, Brockman W, Kim TK, Koche RP, Lee W, Mendenhall E, O'Donovan A, Presser A, Russ C, Xie X, Meissner A, Wernig M, Jaenisch R, Nusbaum C, Lander ES, and Bernstein BE. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448: 553-560, 2007. (Pubitemid 47206934)
118. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, Maeda M, and Yamanaka S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113: 631-642, 2003. (Pubitemid 36694188)
119. Miyoshi K, Tsuji D, Kudoh K, Satomura K, Muto T, Itoh K, and Noma T. Generation of human induced pluripotent stem cells from oral mucosa. J Biosci Bioeng 110: 345-350, 2010.
120. Murry CE and Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132: 661-680, 2008. (Pubitemid 351260059)
121. Nagata S, Toyoda M, Yamaguchi S, Hirano K, Makino H, Nishino K, Miyagawa Y, Okita H, Kiyokawa N, Nakagawa M, Yamanaka S, Akutsu H, Umezawa A, and Tada T. Efficient reprogramming of human and mouse primary extraembryonic cells to pluripotent stem cells. Genes Cells 14: 1395-1404, 2009.
122. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, Mochiduki Y, Takizawa N, and Yamanaka S. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26: 101-106, 2008.
123. Nakagawa M, Takizawa N, Narita M, Ichisaka T, and Yamanaka S. Promotion of direct reprogramming by transformation-deficient Myc. Proc Natl Acad Sci USA 107: 14152-14157, 2010.
124. Newman MA, Thomson JM, and Hammond SM. Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing. RNA 14: 1539-1549, 2008.
125. Nichols J, Chambers I, Taga T, and Smith A. Physiological rationale for responsiveness of mouse embryonic stem cells to gp130 cytokines. Development 128: 2333-2339, 2001. (Pubitemid 32633366)
126. Niwa H. How is pluripotency determined and maintained? Development 134: 635-646, 2007. (Pubitemid 46437906)
127. Niwa H, Miyazaki J, and Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24: 372-376, 2000. (Pubitemid 30187435)
128. Oda Y, Yoshimura Y, Ohnishi H, Tadokoro M, Katsube Y, Sasao M, Kubo Y, Hattori K, Saito S, Horimoto K, Yuba S, and Ohgushi H. Induction of pluripotent stem cells from human third molar mesenchymal stromal cells. J Biol Chem 274: 4400-4411, 2010.
129. Ogawa K, Nishinakamura R, Iwamatsu Y, Shimosato D, and Niwa H. Synergistic action of Wnt and LIF in maintaining pluripotency of mouse ES cells. Biochem Biophys Res Commun 343: 159-166, 2006.
130. Oh SK, Kim HS, Park YB, Seol HW, Kim YY, Cho MS, Ku SY, Choi YM, Kim DW, and Moon SY. Methods for expansion of human embryonic stem cells. Stem Cells 23: 605-609, 2005.
131. Ohgushi M, Matsumura M, Eiraku M, Murakami K, Aramaki T, Nishiyama A, Muguruma K, Nakano T, Suga H, Ueno M, Ishizaki T, Suemori H, Narumiya S, Niwa H, and Sasai Y. Molecular pathway and cell state responsible for dissociation-induced apoptosis in human pluripotent stem cells. Cell Stem Cell 7: 225-239, 2010.
132. Okita K, Ichisaka T, and Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 448: 313-317, 2007. (Pubitemid 47080336)
133. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, and Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322: 949-953, 2008.
134. Okumura-Nakanishi S, Saito M, Niwa H, Ishikawa F. Oct-3/4 and Sox2 regulate Oct-3/4 gene in embryonic stem cells. J Biol Chem 280: 5307-5317, 2005. (Pubitemid 40280004)
135. Osafune K, Caron L, Borowiak M, Martinez RJ, Fitz-Gerald CS, Sato Y, Cowan CA, Chien KR, and Melton DA. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol 26: 313-315, 2008. (Pubitemid 351355125)
136. Pan G and Thomson JA. Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res 17: 42-49, 2007. (Pubitemid 46096423)
137. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C, Hochedlinger K, and Daley GQ. Disease-specific induced pluripotent stem cells. Cell 134: 877-886, 2008.
138. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, and Daley GQ. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451: 141-146, 2008.
139. Park YB, Kim YY, Oh SK, Chung SG, Ku SY, Kim SH, Choi YM, and Moon SY. Alterations of proliferative and differentiation potentials of human embryonic stem cells during long-term culture. Exp Mol Med 40: 98-108, 2008.
140. Qi X, Li TG, Hao J, Hu J, Wang J, Simmons H, Miura S, Mishina Y, and Zhao GQ. BMP4 supports self-renewal of embryonic stem cells by inhibiting mitogen-activated protein kinase pathways. Proc Natl Acad Sci USA 101: 6027-6032, 2004. (Pubitemid 38520522)
141. Qin H, Yu T, Qing T, Liu Y, Zhao Y, Cai J, Li J, Song Z, Qu X, Zhou P, Wu J, Ding M, and Deng H. Regulation of apoptosis and differentiation by p53 in human embryonic stem cells. J Biol Chem 282: 5842-5852, 2007. (Pubitemid 47093795)
142. Raya A, Rodriguez-Piza I, Guenechea G, Vassena R, Navarro S, Barrero MJ, Consiglio A, Castella M, Rio P, Sleep E, Gonzalez F, Tiscornia G, Garreta E, Aasen T, Veiga A, Verma IM, Surralles J, Bueren J, and Izpisua Belmonte JC. Diseasecorrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 460: 53-59, 2009.
143. Richards M, Tan SP, Tan JH, Chan WK, and Bongso A. The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells 22: 51-64, 2004. (Pubitemid 38018781)
144. Rougier N, Bourc'his D, Gomes DM, Niveleau A, Plachot M, Paldi A, and Viegas-Pequignot E. Chromosome methylation patterns during mammalian preimplantation development. Genes Dev 12: 2108-2113, 1998. (Pubitemid 28348034)
145. Santos F and Dean W. Epigenetic reprogramming during early development in mammals. Reproduction 127: 643-651, 2004. (Pubitemid 38878420)
146. Sato N, Meijer L, Skaltsounis L, Greengard P, and Brivanlou AH. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 10: 55-63, 2004. (Pubitemid 38524699)
147. Savatier P, Lapillonne H, van Grunsven LA, Rudkin BB, and Samarut J. Withdrawal of differentiation inhibitory activity/leukemia inhibitory factor up-regulates D-type cyclins and cyclin-dependent kinase inhibitors in mouse embryonic stem cells. Oncogene 12: 309-322, 1996. (Pubitemid 26042568)
148. Schuettengruber B, Chourrout D, Vervoort M, Leblanc B, and Cavalli G. Genome regulation by polycomb and trithorax proteins. Cell 128: 735-745, 2007. (Pubitemid 46273581)
149. Seifinejad A, Taei A, Totonchi M, Vazirinasab H, Hasani SN, Aghdami N, Shahbazi E, Salekdeh GH, and Baharvand H. Generation of human induced pluripotent stem cells from a Bombay individual: moving towards "universaldonor" red blood cells. Biochem Biophys Res Commun 3: 568-574, 2009.
150. Seki T, Yuasa S, Oda M, Egashira T, Yae K, Kusumoto D, Nakata H, Tohyama S, Hashimoto H, Kodaira M, Okada Y, Seimiya H, Fusaki N, Hasegawa M, and Fukuda K. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 7: 11-14, 2010.
151. Shao L, Feng W, Sun Y, Bai H, Liu J, Currie C, Kim J, Gama R, Wang Z, Qian Z, Liaw L, and Wu WS. Generation of iPS cells using defined factors linked via the self-cleaving 2A sequences in a single open reading frame. Cell Res 19: 296-306, 2009.
152. Shi Y, Desponts C, Do JT, Hahm HS, Scholer HR, and Ding S. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3: 568-574, 2008.
153. Shi Y, Do JT, Desponts C, Hahm HS, Scholer HR, and Ding S. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2: 525-528, 2008. (Pubitemid 351729222)
154. Shimada H, Nakada A, Hashimoto Y, Shigeno K, Shionoya Y, and Nakamura T. Generation of canine induced pluripotent stem cells by retroviral transduction and chemical inhibitors. Mol Reprod Dev 77: 2, 2010.
155. Silva J, Barrandon O, Nichols J, Kawaguchi J, Theunissen TW, and Smith A. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol 6: e253, 2008.
156. Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, Hargus G, Blak A, Cooper O, Mitalipova M, Isacson O, and Jaenisch R. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136: 964-977, 2009.
157. Sommer CA, Stadtfeld M, Murphy GJ, Hochedlinger K, Kotton DN, and Mostoslavsky G. Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 27: 543-549, 2009.
158. Sridharan R, Tchieu J, Mason MJ, Yachechko R, Kuoy E, Horvath S, Zhou Q, and Plath K. Role of the murine reprogramming factors in the induction of pluripotency. Cell 136: 364-377, 2009.
159. Stadtfeld M, Brennand K, and Hochedlinger K. Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Curr Biol 18: 890-894, 2008.
160. Stadtfeld M, Nagaya M, Utikal J, Weir G, and Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 322: 945-949, 2008.
161. Staerk J, Dawlaty MM, Gao Q, Maetzel D, Hanna J, Sommer CA, Mostoslavsky G, and Jaenisch R. Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell 7: 20-24, 2010.
162. Stead E, White J, Faast R, Conn S, Goldstone S, Rathjen J, Dhingra U, Rathjen P, Walker D, and Dalton S. Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities. Oncogene 21: 8320-8333, 2002. (Pubitemid 35477872)
163. Stock JK, Giadrossi S, Casanova M, Brookes E, Vidal M, Koseki H, Brockdorff N, Fisher AG, and Pombo A. Ring1-mediated ubiquitination of H2A restrains poised RNA polymerase II at bivalent genes in mouse ES cells. Nat Cell Biol 9: 1428-1435, 2007. (Pubitemid 350201756)
164. Sugii S, Kida Y, Kawamura T, Suzuki J, Vassena R, Yin YQ, Lutz MK, Berggren WT, Izpisua Belmonte JC, and Evans RM. Human and mouse adipose-derived cells support feeder-independent induction of pluripotent stem cells. Proc Natl Acad Sci USA 107: 3558-3563, 2010.
165. Suh MR, Lee Y, Kim JY, Kim SK, Moon SH, Lee JY, Cha KY, Chung HM, Yoon HS, Moon SY, Kim VN, and Kim KS. Human embryonic stem cells express a unique set of microRNAs. Dev Biol 270: 488-498, 2004. (Pubitemid 38748567)
166. Sumi T, Tsuneyoshi N, Nakatsuji N, and Suemori H. Apoptosis and differentiation of human embryonic stem cells induced by sustained activation of c-Myc. Oncogene 26: 5564-5576, 2007. (Pubitemid 47267844)
167. Sun N, Panetta NJ, Gupta DM, Wilson KD, Lee A, Jia F, Hu S, Cherry AM, Robbins RC, Longaker MT, and Wu JC. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci USA 106: 15720-15725, 2009.
168. Suzuki A, Raya A, Kawakami Y, Morita M, Matsui T, Nakashima K, and Gage FH, Rodriguez-Esteban C, Izpisua Belmonte JC. Maintenance of embryonic stem cell pluripotency by Nanog-mediated reversal of mesoderm specification. Nat Clin Pract Cardiovasc Med 3 suppl 1: S114-S122, 2006.
169. Szabo PE, Hubner K, Scholer H, and Mann JR. Allelespecific expression of imprinted genes in mouse migratory primordial germ cells. Mech Dev 115: 157-160, 2002. (Pubitemid 34615682)
170. Tachibana M, Matsumura Y, Fukuda M, Kimura H, and Shinkai Y. G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription. EMBO J 27: 2681-2690, 2008.
171. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, and Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872, 2007. (Pubitemid 350138099)
172. Takahashi K and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676, 2006. (Pubitemid 44233629)
173. Takenaka C, Nishishita N, Takada N, Jakt LM, and Kawamata S. Effective generation of iPS cells from CD34 + cord blood cells by inhibition of p53. Exp Hematol 38: 154-162, 2010.
174. Tat PA, Sumer H, Jones KL, Upton K, and Verma PJ. The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells. Cell Transplant 19: 525-536, 2010.
175. Tesar PJ, Chenoweth JG, Brook FA, Davies TJ, Evans EP, Mack DL, Gardner RL, and McKay RD. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448: 196-199, 2007. (Pubitemid 47067378)
176. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, and Jones JM. Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147, 1998. (Pubitemid 28516247)
177. Tokuzawa Y, Kaiho E, Maruyama M, Takahashi K, Mitsui K, Maeda M, Niwa H, and Yamanaka S. Fbx15 is a novel target of Oct3/4 but is dispensable for embryonic stem cell self-renewal and mouse development. Mol Cell Biol 23: 2699-708, 2003. (Pubitemid 36403071)
178. Tomioka I, Maeda T, Shimada H, Kawai K, Okada Y, Igarashi H, Oiwa R, Iwasaki T, Aoki M, Kimura T, Shiozawa S, Shinohara H, Suemizu H, Sasaki E, and Okano H. Generating induced pluripotent stem cells from common marmoset (Callithrix jacchus) fetal liver cells using defined factors, including Lin28. Genes Cells 15: 959, 2010.
179. Tsai SY, Clavel C, Kim S, Ang YS, Grisanti L, Lee DF, Kelley K, and Rendl M. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells. Stem Cells 28: 221-228, 2010.
180. Ura H, Usuda M, Kinoshita K, Sun C, Mori K, Akagi T, Matsuda T, Koide H, and Yokota T. STAT3 and Oct-3/4 control histone modification through induction of Eed in embryonic stem cells. J Biol Chem 283: 9713-9723, 2008.
181. Utikal J, Maherali N, Kulalert W, and Hochedlinger K. Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J Cell Sci 122: 3502-3510, 2009.
182. Utikal J, Polo JM, Stadtfeld M, Maherali N, Kulalert W, Walsh RM, Khalil A, Rheinwald JG, and Hochedlinger K. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 460: 1145-1148, 2009.
183. Vallier L, Alexander M, and Pedersen RA. Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J Cell Sci 118: 4495-4509, 2005. (Pubitemid 41556347)
184. Varas F, Stadtfeld M, de Andres-Aguayo L, Maherali N, di Tullio A, Pantano L, and Notredame C, Hochedlinger K, Graf T. Fibroblast-derived induced pluripotent stem cells show no common retroviral vector insertions. Stem Cells 27: 300-306, 2009.
185. Vercelli A, Mereuta OM, Garbossa D, Muraca G, Mareschi K, Rustichelli D, Ferrero I, Mazzini L, Madon E, and Fagioli F. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 31: 395-405, 2008.
186. Viswanathan SR, Daley GQ, and Gregory RI. Selective blockade of microRNA processing by Lin28. Science 320: 97-100, 2008. (Pubitemid 351490762)
187. Wang J, Rao S, Chu J, Shen X, Levasseur DN, Theunissen TW, and Orkin SH. A protein interaction network for pluripotency of embryonic stem cells. Nature 444: 364-368, 2006. (Pubitemid 44764111)
188. Wang Y, Baskerville S, Shenoy A, Babiarz JE, Baehner L, and Blelloch R. Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nat Genet 40: 1478-1483, 2008.
189. Wang Y, Jiang Y, Liu S, Sun X, and Gao S. Generation of induced pluripotent stem cells from human beta-thalassemia fibroblast cells. Cell Res 19: 1120-1123, 2009.
190. Wernig M, Lengner CJ, Hanna J, Lodato MA, Steine E, Foreman R, Staerk J, Markoulaki S, and Jaenisch R. A druginducible transgenic system for direct reprogramming of multiple somatic cell types. Nat Biotechnol 26: 916-924, 2008.
191. Wernig M, Meissner A, Cassady JP, and Jaenisch R. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2: 10-12, 2008.
192. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE, and Jaenisch R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448: 318-324, 2007. (Pubitemid 47080337)
193. Wernig M, Zhao JP, Pruszak J, Hedlund E, Fu D, Soldner F, Broccoli V, Constantine-Paton M, Isacson O, and Jaenisch R. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci USA 105: 5856-5861, 2008. (Pubitemid 351758462)
194. Williams RL, Hilton DJ, Pease S, Willson TA, Stewart CL, Gearing DP, Wagner EF, Metcalf D, Nicola NA, and Gough NM. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336: 684-687, 1988. (Pubitemid 19007951)
195. Wilmut I, Schnieke AE, McWhir J, Kind AJ, and Campbell KH. Viable offspring derived from fetal and adult mammalian cells. Nature 385: 810-813, 1997. (Pubitemid 27106068)
196. Wilson KD, Venkatasubrahmanyam S, Jia F, Sun N, Butte AJ, and Wu JC. MicroRNA profiling of human-induced pluripotent stem cells. Stem Cells Dev 18: 749-758, 2009.
197. Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hamalainen R, Cowling R, Wang W, Liu P, Gertsenstein M, Kaji K, Sung HK, and Nagy A. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458: 766-770, 2009.
198. Wright WE and Shay JW. The two-stage mechanism controlling cellular senescence and immortalization. Exp Gerontol 27: 383-389, 1992.
199. Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, Lingner J, and Dalla-Favera R. Direct activation of TERT transcription by c-MYC. Nat Genet 21: 220-224, 1999. (Pubitemid 29070372)
200. Wu Q, Chen X, Zhang J, Loh YH, Low TY, Zhang W, Sze SK, Lim B, and Ng HH. Sall4 interacts with Nanog and cooccupies Nanog genomic sites in embryonic stem cells. J Biol Chem 281: 24090-24094, 2006. (Pubitemid 44274183)
201. Wu X, Li Y, Crise B, and Burgess SM. Transcription start regions in the human genome are favored targets for MLV integration. Science 300: 1749-1751, 2003. (Pubitemid 36712571)
202. Wu Z, Chen J, Ren J, Bao L, Liao J, Cui C, Rao L, Li H, Gu Y, Dai H, Zhu H, Teng X, Cheng L, and Xiao L. Generation of pig induced pluripotent stem cells with a drug-inducible system. J Mol Cell Biol 1: 46-54, 2009.
203. Xu C, Rosler E, Jiang J, Lebkowski JS, Gold JD, O'Sullivan C, Delavan-Boorsma K, Mok M, Bronstein A, and Carpenter MK. Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium. Stem Cells 23: 315-323, 2005. (Pubitemid 40404450)
204. Xu RH, Chen X, Li DS, Li R, Addicks GC, Glennon C, Zwaka TP, and Thomson JA. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat Biotechnol 20: 1261-1264, 2002. (Pubitemid 35462493)
205. Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 1: 39-49, 2007. (Pubitemid 46865811)
206. Ye Z, Zhan H, Mali P, Dowey S, Williams DM, Jang YY, Dang CV, Spivak JL, Moliterno AR, and Cheng L. Human induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood 114: 5473-5480, 2009.
207. Ying QL, Nichols J, Chambers I, and Smith A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115: 281-292, 2003. (Pubitemid 37487702)
208. Ying QL, Wray J, Nichols J, Batlle-Morera L, Doble B, Woodgett J, Cohen P, and Smith A. The ground state of embryonic stem cell self-renewal. Nature 453: 519-523, 2008. (Pubitemid 351733324)
209. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F, Lieberman J, and Song E. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131: 1109-1123, 2007. (Pubitemid 350235025)
210. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin, II, and Thomson JA. Human induced pluripotent stem cells free of vector and transgene sequences. Science 324: 797-801, 2009.
211. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, and Thomson JA. Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920, 2007.
212. Yusa K, Rad R, Takeda J, and Bradley A. Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat Methods 6: 363-369, 2009.
213. Zaehres H, Kogler G, Arauzo-Bravo MJ, Bleidissel M, Santourlidis S, Weinhold S, Greber B, Kim JB, Buchheiser A, Liedtke S, Eilken HM, Graffmann N, Zhao X, Meyer J, Reinhardt P, Burr B, Waclawczyk S, Ortmeier C, Uhrberg M, Scholer HR, Cantz T, and Wernet P. Induction of pluripotency in human cord blood-unrestricted somatic stem cells. Exp Hematol 131: 834, 2010.
214. Zhang J, Tam WL, Tong GQ, Wu Q, Chan HY, Soh BS, Lou Y, Yang J, Ma Y, Chai L, Ng HH, Lufkin T, Robson P, and Lim B. Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Nat Cell Biol 8: 1114-1123, 2006. (Pubitemid 44473607)
215. Zhang YW, Denham J, and Thies RS. Oligodendrocyte progenitor cells derived from human embryonic stem cells express neurotrophic factors. Stem Cells Dev 15: 943-952, 2006. (Pubitemid 46147864)
216. Zhao HX, Li Y, Jin HF, Xie L, Liu C, Jiang F, Luo YN, Yin GW, Wang J, Li LS, Yao YQ, and Wang XH. Rapid and efficient reprogramming of human amnion-derived cells into pluripotency by three factors OCT4/SOX2/NANOG. Differentiation 80: 123-129, 2010.
217. Zhao XY, Li W, Lv Z, Liu L, Tong M, Hai T, Hao J, Guo CL, Ma QW, Wang L, Zeng F, and Zhou Q. iPS cells produce viable mice through tetraploid complementation. Nature 461: 86-90, 2009.
218. Zheng H, Ying H, Yan H, Kimmelman AC, Hiller DJ, Chen AJ, Perry SR, Tonon G, Chu GC, Ding Z, Stommel JM, Dunn KL, Wiedemeyer R, You MJ, Brennan C, Wang YA, Ligon KL, Wong WH, Chin L, and DePinho RA. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature 455: 1129-1133, 2008.
219. Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T, Trauger S, Bien G, Yao S, Zhu Y, Siuzdak G, Scholer HR, Duan L, and Ding S. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4: 381-384, 2009.
220. Zhou Q, Chipperfield H, Melton DA, and Wong WH. A gene regulatory network in mouse embryonic stem cells. Proc Natl Acad Sci USA 104: 16438-16443, 2007. (Pubitemid 350211036)
221. Zhou W and Freed CR. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells 27: 2667-2674, 2009.